These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24982689)

  • 1. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells.
    Tang ZH; Li T; Gao HW; Sun W; Chen XP; Wang YT; Lu JJ
    Chin Med; 2014; 9():16. PubMed ID: 24982689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of HSP90
    Jokar F; Mahabadi JA; Salimian M; Taherian A; Hayat SMG; Sahebkar A; Atlasi MA
    J Pharmacopuncture; 2019 Mar; 22(1):28-34. PubMed ID: 30988998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic Acid Incorporation Is Not Affected by Doxorubicin Chemotherapy in either Whole Cell or Lipid Raft Phospholipids of Breast Cancer Cells in vitro and Tumor Phospholipids in vivo.
    Newell M; Patel D; Goruk S; Field CJ
    Lipids; 2020 Sep; 55(5):549-565. PubMed ID: 32588470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
    Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin inhibits miR-140 expression and upregulates PD-L1 expression in HCT116 cells, opposite to its effects on MDA-MB-231 cells.
    Naba NM; Tolay N; Erman B; Sayi Yazgan A
    Turk J Biol; 2020; 44(1):15-23. PubMed ID: 32123492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
    Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells.
    Wu GS; Lu JJ; Guo JJ; Huang MQ; Gan L; Chen XP; Wang YT
    Pharmacol Rep; 2013; 65(2):453-9. PubMed ID: 23744430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.
    Wang Q; Liang D; Shen P; Yu Y; Yan Y; You W
    Transl Oncol; 2021 Aug; 14(8):101045. PubMed ID: 34023560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or Docetaxel.
    Taherian A; Mazoochi T
    Iran J Basic Med Sci; 2012 Jan; 15(1):669-77. PubMed ID: 23493035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells.
    Malekinejad F; Kheradmand F; Khadem-Ansari MH; Malekinejad H
    Daru; 2022 Jun; 30(1):103-115. PubMed ID: 35113358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels.
    Koşar PA; Nazıroğlu M; Övey İS; Çiğ B
    J Membr Biol; 2016 Apr; 249(1-2):129-40. PubMed ID: 26525975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
    Han M; Vakili MR; Soleymani Abyaneh H; Molavi O; Lai R; Lavasanifar A
    Mol Pharm; 2014 Aug; 11(8):2640-9. PubMed ID: 24811541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
    Lin PH; Lin CH; Huang CC; Chuang MC; Lin P
    Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effect of Bioactive Anticarcinogens from Soybean on Anti-Proliferative Activity in MDA-MB-231 and MCF-7 Human Breast Cancer Cells In Vitro.
    Zhu Y; Yao Y; Shi Z; Everaert N; Ren G
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29954123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
    Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
    Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach.
    Fleisher B; Lezeau J; Werkman C; Jacobs B; Ait-Oudhia S
    Breast Cancer (Dove Med Press); 2021; 13():87-105. PubMed ID: 33628047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.